retatrutide news october 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation New weight loss drug dubbed

Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis from the Randomized Active- and Placebo-Controlled SURPASS-15 Clinical Trials

It's unflavored and is made of a grit-free powder that dissolves completely in hot or cold liquid

It makes fats in the blood better, lowers blood pressure, and helps control sugar levels

It remains an investigational peptide used in clinical and research settings outside of formal FDA-approved indications

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man

Parkinson's disease is a progressive neurodegenerative disorder characterised by the loss of dopaminergic neurons in the substantia nigra, a region of the brain crucial for movement control